# Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence

> **NCT03239964** · PHASE4 · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 146 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** surgical excision

## Key facts

- **NCT ID:** NCT03239964
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-10
- **Primary completion:** 2018-01-24
- **Final completion:** 2018-01-24
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239964, "Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03239964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*